KVUE - Kenvue Inc Net earnings per share (EPS TTM)

Symbol and logo of brand Kenvue (KVUE)

Kenvue Inc. relies on a global portfolio of recognizable hygiene brands, which ensures revenue stability. Fundamental TTM earnings per share demonstrate yield dynamics, where 0.88 reflects the latest value of the metric. Consumer loyalty allows the company to index prices according to inflation. Meanwhile, updated management is successfully optimizing operational processes, strengthening the business's market positions.

KVUE (Kenvue Inc.) Net earnings per one share for the last twelve months history from 02/21/2024 to 11/14/2026

Summary analytical data breakdowns for Kenvue Corp (KVUE)

- share price and expert price forecast:
Stock Quotes Kenvue Inc.|KVUE - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Kenvue Health|KVUE - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Kenvue|KVUE - Total Stockholders' Equity|Market Value to Book Value Ratio kenvue.com|KVUE - Aggregate Asset Value
- debt obligations and liquidity statistics:
Debt to Equity Kenvue Inc.|KVUE - Long-Term Debt to Capital|Short-Term Debt to Capital Kenvue Inc|KVUE - Company Cumulative Debt|Debt to Book Capitalization Ratio Kenvue|KVUE - Company Long-Term Indebtedness|Company Current Liabilities Kenvue|Quick Liquidity Indicator kenvue.com
- net income and valuation multiples indicators:
KVUE - Net Profit|Projected Future Earnings Kenvue Inc.|KVUE - Market Cap to Earnings|Projected Price to Earnings Kenvue Corp|KVUE - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Kenvue|KVUE - Operating income before deduction of amortization|Earnings per share for the last twelve months Kenvue|KVUE - Earnings per share for the last 12 months|Quarterly EPS earnings growth kenvue.com|KVUE - Net earnings per share growth this year|Expected earnings per share growth for next year Kenvue Inc.
- revenue and sales proceeds data:
KVUE - Company Gross Revenue|Company Projected Revenue kenvue.com|KVUE - P/S Multiple|Forward Price-to-Revenue Multiple Kenvue Corp
Basic company analysis:KVUE - Kenvue Corp
Mass-produced product of Kenvue Inc

Legal costs associated with legacy products and pressure from private labels are limiting the pricing power of Kenvue Inc. (KVUE), directly impacting operating margins. By analyzing net income per share, investors can assess real equity returns adjusted for issuance volume, allowing for a real-time assessment of depleting growth drivers and the determination of the business's fair market capitalization.

Direct competitors

Haleon - Net earnings per share (EPS TTM)|Verona Pharma - Earnings per share for the last four quarters|MENS: Net earnings per share (EPS TTM)|Ligand Pharma - Earnings per share for the trailing year|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months perrigo.com PRGO|Earnings per share for the last twelve months Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) GLPG (Galapagos N.V.)|Net earnings per share (EPS TTM) ANI Pharmaceuticals Corp ANIP|Afrezza - Net earnings per share (EPS TTM)|amphastar.com (AMPH) - Net earnings per share for the last 12 months|PCRX: Net earnings per share (EPS TTM)|SPRY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Theravance|Net earnings per one share for the last twelve months Aquestive Corp AQST|Net earnings per share (EPS TTM) SCPH|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP